fr   en
Clinical Studies
Phase :    
Announcement :   
Select a Pharma :
Select a product :
Select a disease :
Choose date:
[<<]      «      47   |   48   |   49   |   50   |   51   |   52   |   53   |   54   |   55   |   56   |   57      »      [57]
Date Phase Anouncement Biotech Pharma Product Disease Country Other
2006-12-13 I Launch Crucell (The Netherlands)   antirabies monoclonal antibody rabies USA See details
2006-12-13 I Launch Trigen (UK-Germany)   PR-15 (soluble form of the GPVI receptor - platelet adhesion inhibitor) arterial thrombosis Germany See details
2006-12-13 I Launch Trigen (Germany and UK)   PR-15 (protein corresponding to the soluble form of the GPVI receptor - platelet adhesion inhibitor) acute arterial thrombosis - prevention of the progression of atherosclerosis after an acute myocardial infarction Germany See details
2006-12-12 II Launch Pharmexa (Denmark)   GV1001 (peptide vaccine for the activation of T lymphocytes) non-small-cell lung cancer Norway See details
2006-12-12 II Result Curagen (USA)/TopoTarget (Denmark)   PXD101(histone deacetylase inhibitor) multiple myeloma   See details
2006-12-11 III Launch Actelion (Switzerland)   Actelion-1 (endothelin receptor antagonist) pulmonary hypertension   See details
2006-12-11 II Result Genmab (Denmark)   HuMax-CD4® (zanolimumab) Non-cutaneous T-cell lymphoma   See details
2006-12-11 I Launch Vernalis (UK)   V24343 (a CB1 cannabinoid receptor antagonist) obesity and related pathologies such as type 2 diabetes.   See details
2006-12-11 II Launch Genmab (Denmark)   HuMax-CD20® (ofatumumab) chronic lymphoid leukaemia   See details
2006-12-11 II Launch Antisoma (UK)   AS1411 acute myeloid leukaemia   See details
2006-12-04 II Launch 4SC (Germany)   SC12267 (dihydroorotate dehydrogenase inhibitor) rheumatoid arthritis Germany See details
2006-11-30 III Result Arpida (Switzerland)   iclaprim severe infections of the skin and cutaneous tissues, including infections linked to methicillin-resistant Staphylococcus aureus (MRSA)   See details
2006-11-27 I Launch Arrow Therapeutics (UK)   A-831 antiviral hepatitis C   See details
2006-11-27 II Launch Pharmexa (Denmark)   GV1001 (peptide vaccine for the activation of T lymphocytes) hepatocellular carcinoma Germany, France, Spain See details
2006-11-16 II Launch Curagen (USA)/TopoTarget (Denmark)   Belinostat-PXD101 (histone deacetylase inhibitor) ovarian cancer USA and Canada See details
[<<]      «      47   |   48   |   49   |   50   |   51   |   52   |   53   |   54   |   55   |   56   |   57      »      [57]